For emerging life sciences organizations, speed, efficiency, and scalability are keys to success.
This on-demand webinar outlines the technology and digital processes that companies like yours have used to successfully commercialize and grow their businesses, while remaining nimble and efficient. Whether you are scaling out of R&D or preparing for commercial launch, the session focuses on building an IT foundation that grows with you instead of holding you back.
What you'll learn
- How to move core processes from paper to the cloud without disrupting day-to-day operations.
- The common challenges emerging companies face when implementing new IT systems — and how to avoid them.
- How to build a practical roadmap for automating your business and GxP processes.
- Where workflow integrations and system synergies maximize efficiency while minimizing cost and compliance risk.
- Answers from a live Q&A on real-world adoption questions.
Why this matters
Emerging life sciences companies rarely fail for lack of science — they get slowed down by manual processes and IT systems that were never designed to scale from R&D to commercial. Getting the digital foundation right early is what lets a growing organization stay nimble while still meeting the regulatory expectations that come with bringing a product to market.
USDM's point of view: Technology for an emerging life sciences company should reduce risk, not add it. We help organizations move from paper to the cloud with validated, audit-ready systems — pairing automation of GxP processes with 21 CFR Part 11 compliance and a modern Computer Software Assurance (CSA) approach so that speed and compliance reinforce each other rather than compete.
Inside the session
The webinar walks through the journey from R&D to commercial: where paper-based workflows create the most friction, how to sequence an automation roadmap, and how to integrate systems so data flows cleanly across the business. Strong data integrity practices and continuous compliance for cloud systems are recurring themes, because the goal is an IT environment that stays inspection-ready as the company grows.
About the presenter
Roger Davy, Director of Customer Engagement
FAQ: IT systems for emerging life sciences
Who is this webinar for?
It is designed for emerging life sciences organizations that are scaling from R&D toward commercialization and need IT systems that keep them efficient, compliant, and nimble as they grow.
What does "paper to the cloud" actually involve?
It means replacing manual, paper-based workflows with cloud systems that automate business and GxP processes. The session covers how to make that shift in a way that improves efficiency while keeping data integrity and compliance intact.
How do we automate GxP processes without increasing compliance risk?
By building a roadmap that automates the right processes in the right order and validates systems with a risk-based approach such as Computer Software Assurance. The webinar discusses how workflow integrations can minimize both cost and compliance risk at the same time.
What are the common challenges emerging companies hit when implementing IT systems?
The session addresses challenges such as choosing and sequencing systems, integrating workflows, and standing up validated, audit-ready processes early enough to support commercial growth.
How can USDM help after I watch?
USDM helps emerging life sciences companies plan and execute their move to cloud systems with validation, GxP automation, and USDM Cloud Assurance for ongoing compliance. Contact us to talk through your roadmap.
Watch the on-demand webinar to see the full discussion and live Q&A on building IT systems for emerging life sciences — from R&D to commercial. Ready to map your own roadmap? Contact USDM to get started.